{"id":"F2015L01053","name":"Financial Sector (Collection of Data) (reporting standard) determination No. 32 of 2015","slug":"financial-sector-collection-of-data-reporting-standard-determination-no-32-of-2015","collection":"legislative_instrument","jurisdiction":"commonwealth","status":"repealed","isInForce":false,"actNumber":null,"makingDate":null,"administeringDepartment":null,"currentVersion":{"id":128958,"registerId":"commonwealth-F2015L01053-current","compilationNumber":null,"startDate":"2026-04-03","status":"Repealed","reasons":null,"registeredAt":null},"sections":[{"sectionNumber":"1","sectionType":"section","heading":"Financial Sector (Collection of Data) (reporting standard) determination No. 32 of 2015","content":"![](image.001.png)\n\nFinancial Sector (Collection of Data) (reporting standard) determination No. 32 of 2015\n\nReporting Standard HRS 602.0 Financial and Capital Data\n\nFinancial Sector (Collection of Data) Act 2001\n\nI, Ian Laughlin, delegate of APRA, under paragraph 13(1)(a) of the Financial Sector (Collection of Data) Act 2001 (the Act) DETERMINE Reporting Standard HRS 602.0 Financial and Capital Data, in the form set out in the Schedule, which applies to the financial sector entities to the extent provided in paragraph 3 of the reporting standard.\n\nUnder section 15 of the Act, I DECLARE that the reporting standard shall begin to apply to those financial sector entities on the day that the Private Health Insurance (Prudential Supervision) Act 2015 commences.\n\nThis instrument commences on the day that the Private Health Insurance (Prudential Supervision) Act 2015 commences.\n\nDated: 26 June 2015\n\n\\[Signed\\]\n\nIan Laughlin\n\nDeputy Chairman\n\nInterpretation\n\nIn this Determination:\n\nAPRA means the Australian Prudential Regulation Authority.\n\nfinancial sector entity has the meaning given by section 5 of the Act.\n\nSchedule\n\nReporting Standard HRS 602.0 Financial and Capital Data comprises the 39 pages commencing on the following page.\n\n![](image.001.png)\n\nReporting Standard HRS 602.0\n\nFinancial and Capital Data\n\nObjective of this Reporting Standard\n\nThis Reporting Standard sets out the requirements for the provision of information to APRA regarding a private health insurer’s capital adequacy, solvency and financial position.\n\nIt includes Form HRF 602.0 Financial and Capital Data – Cover Page, Form HRF 602.1 Financial and Capital Data – CA Forecasts, Form HRF 602.2 Financial and Capital Data – Solvency Forecasts, Form HRF 602.3 Financial and Capital Data – Revenue, Form HRF 602.4 Financial and Capital Data – Expenses, Form HRF 602.5 Financial and Capital Data – Capital Transfers, Form HRF 602.6 Financial and Capital Data – Assets, Form HRF 602.7 Financial and Capital Data – Liabilities, Form HRF 602.8 Financial and Capital Data – Related Party Disclosures and Form HRF 602.9 Financial and Capital Data – Claims Data and associated specific instructions.\n\nAuthority\n\n1. This Reporting Standard is made under section 13 of the Financial Sector (Collection of Data) Act 2001.\n\nPurpose\n\n2. Information collected under this Reporting Standard, as set out in, Form HRF 602.0 Financial and Capital Data – Cover Page, Form HRF 602.1 Financial and Capital Data – CA Forecasts, Form HRF 602.2 Financial and Capital Data – Solvency Forecasts, Form HRF 602.3 Financial and Capital Data – Revenue, Form HRF 602.4 Financial and Capital Data – Expenses, Form HRF 602.5 Financial and Capital Data – Capital Transfers, Form HRF 602.6 Financial and Capital Data – Assets, Form HRF 602.7 Financial and Capital Data – Liabilities, Form HRF 602.8 Financial and Capital Data – Related Party Disclosures and Form HRF 602.9 Financial and Capital Data – Claims Data (the HRF 602.0 series), is used by APRA for the purposes of prudential supervision (including assessing compliance with capital adequacy and solvency standards) and for publication.\n\nApplication and commencement\n\n3. This Reporting Standard applies to all private health insurers.\n\n4. This Reporting Standard applies for reporting periods ending on or after the day that the Private Health Insurance (Prudential Supervision) Act 2015 commences.\n\nInformation required\n\n 5. A private health insurer must provide APRA with the information required by this Reporting Standard in respect of each reporting period.\n 6. The information required by this Reporting Standard, as set out in the HRF 602.0 series of forms, must be provided for each health benefits fund of the private health insurer.\n\nForms and method of submission\n\n 7. The information required by this reporting standard must be lodged as electronic data via the PHIAC Extranet, or an alternate method notified by APRA, in writing, prior to submission.\n\nReporting periods and due dates\n\n 8. Subject to paragraph 9, a private health insurer to which this Reporting Standard applies must provide the information required by this Reporting Standard:\n (a) in respect of each calendar quarter (i.e. the periods ending 30 September, 31 December, 31 March and 30 June); and\n (b) in respect of each year ending 30 June.\n 9. If, having regard to the particular circumstances of a private health insurer, APRA considers it necessary or desirable to obtain information more or less frequently than as provided by paragraph 8, APRA may change the reporting periods, or specify reporting periods, for the particular private health insurer.\n 10. The information required by this Reporting Standard must be provided to APRA:\n (a) in the case of quarterly information – within 28 calendar days after the end of the reporting period to which the information relates;[\\[1\\]](#_ftn1) and\n (b) in the case of annual information – by 30 September each year.\n 11. APRA may, in writing, grant a private health insurer an extension of a due date, in which case the new due date for the provision of the information will be the date on the notice of extension.\n\nQuality control\n\n 12. All information provided by a private health insurer under this Reporting Standard must be subject to systems, processes and controls developed by the private health insurer for the internal review and authorisation of that information. It is the responsibility of the Board and senior management of the private health insurer to ensure that an appropriate set of policies and procedures for the authorisation of information submitted to APRA is in place.\n\nAnnual audit requirements\n\n 13. The information submitted for the purposes of paragraph 10(b) is to be subject to external audit to ensure consistency with the private health insurer’s statutory financial accounts and faithful application of the solvency and capital adequacy standards.\n 14. Audit certification and opinion must be provided to APRA by 30 September each year.\n 15. If a private health insurer received a qualified auditor’s report for a health benefits fund for the year previous to the year for which the report is provided, the report for the year for which the report is provided must state whether the auditor has examined the issues identified and is satisfied that the private health insurer has taken the appropriate steps to rectify the matters raised in the previous report.\n 16. The auditor’s report must:\n (a) state details of the program adopted to carry out the audit; and\n (b) include the name of, and be signed by, the auditor who takes responsibility for the accuracy of the report.\n\nAuthorisation\n\n 17. A person who submits the information required under this Reporting Standard must be suitably authorised by an officer of the private health insurer.\n\nVariations\n\n 18. APRA may, in writing, vary the reporting requirements of this Reporting Standard in relation to a private health insurer.\n\nTransitional\n\n 19. Any approval, determination or other exercise of discretion, made prior to the commencement of this reporting standard by PHIAC in relation to the PHIAC 2 return, will continue to have effect after the commencement of this reporting standard, as if made under this reporting standard, until revoked by APRA.\n 20. Information that would have been required to be submitted to PHIAC on the PHIAC 2 return in respect of the quarter or year ending 30 June 2015 must instead be submitted to APRA as though it was required under this Reporting Standard.\n 21. Information that had previously been required to be submitted to PHIAC on the PHIAC 2 return relating to a period ending before 30 June 2015, but which had not been submitted to PHIAC by the end of 30 June 2015, must be submitted to APRA.\n 22. If, at the end of 30 June 2015, a private health insurer was under an obligation to submit an amended return, to replace a return that the private health insurer submitted to PHIAC prior to 1 July 2015, the private health insurer must submit the amended return to APRA as soon as practicable.\n 23. If APRA, acting reasonably, is satisfied that information submitted by a private health insurer to PHIAC on the PHIAC 2 return prior to 1 July 2015 is inaccurate, APRA may, by notifying the private health insurer in writing of the basis of APRA’s concern, require resubmission of that information in a way that corrects the inaccuracy.\n\nInterpretation\n\n 24. In this Reporting Standard:\n (a) unless the contrary intention appears, words and expressions have the meanings given to them in Prudential Standard HPS 001 Definitions (HPS 001); and\n (b) APRA means the Australian Prudential Regulation Authority established under the Australian Prudential Regulation Authority Act 1998;\n\nHRF 602.0 series of forms means Form HRF 602.0 Financial and Capital Data – Cover Page, Form HRF 602.1 Financial and Capital Data – CA Forecasts, Form HRF 602.2 Financial and Capital Data – Solvency Forecasts, Form HRF 602.3 Financial and Capital Data – Revenue, Form HRF 602.4 Financial and Capital Data – Expenses, Form HRF 602.5 Financial and Capital Data – Capital Transfers, Form HRF 602.6 Financial and Capital Data – Assets, Form HRF 602.7 Financial and Capital Data – Liabilities, Form HRF 602.8 Financial and Capital Data – Related Party Disclosures and Form HRF 602.9 Financial and Capital Data – Claims Data;\n\n officer has the meaning in the Private Health Insurance (Prudential Supervision) Act 2015;\n PHIAC means the Private Health Insurance Administration Council continued in existence under subsection 264-1(1) of the Private Health Insurance Act 2007, as it existed immediately prior to the commencement of the Private Health Insurance (Prudential Supervision) Act 2015;\n PHIAC 2 return means the form titled PHIAC 2 return issued under subclause 4(6) of Schedule 2 and section 4(3) of Schedule 3 of the Private Health Insurance (Health Benefits Fund Administration) Rules 2013, as they existed immediately prior to the commencement of the Private Health Insurance (Prudential Supervision) Act 2015;\n PHIAC Extranet is an environment (based on SharePoint) for secure (user ID and password required) sharing of documents, accessible via the internet;\n private health insurer has the meaning in the Private Health Insurance (Prudential Supervision) Act 2015: and\n\nreporting period means a period mentioned in paragraph 8 or, if applicable, paragraph 9. \n\n```html\n

Form 602.0 Financial and Capital Data ‐ Cover Page

Cover Page

1a: Lodgement details

Health benefits fund: Insurer's Australian Business Number: Period ended:

Period length:

1b: Contact details for this return

Contact Name: Position: Phone number: Email address:

\n```\n\n![](image.002.png)\n\n```html\n

New HIB policies: new to PHI (#)

New HIB policies: new to PHI ‐ average monthly premium rate ($ New HIB policies: transfers (#)

New HIB policies: transfers ‐ average monthly premium rate ($ Terminated policies (#)

Terminated policies ‐ average monthly premium rate ($

month 1 month 2 month 3 month 4 month 5 month 6 month 7 month 8 month 9 month 10 month 11 month 12

Hospital SEUs (#) HIB Premium increase assumed in central estimate projection (% HIB Premium increase, given the STAC (%

HIB Contribution income, central estimate ($ HIB Contribution income, given the STAC ($

HRB Income ($)

HIB Gross margin (%) HIB Net margin (%)

Investment income margin (%)

HRB and other income margin (%)

Capital transfers in/(out) of the fund ($

Section 2: Stressed estimates

xth percentile (%)

Forecasts month 1 month 2 month 3 month 4 month 5 month 6 month 7 month 8 month 9 month 10 month 11 month 12 annual value

HIB Net margin (%)

NM% (%)

Investment income margin (%)

Stressed Investment Income Estimate ($

HRB and other income margin (%)

Stressed Other Income Estimate ($

Tax (%)

Tax ($)

\n```\n\n![](image.003.png)\n\n```html\n

Cash Outflows ($)

Cash Inflows: Premiums ($) Investment Revenue ($) Maturing Investments ($) Other cash inflows due ($)

1b: Stressed Net Cash Outflow Amount

Stressed Net Cash Outflow Amount ($)

\n```\n\n![](image.006.png)![](image.005.png)![](image.004.png)\n\n```html\n

Hospital Treatment ($) General Treatment and Ambulance ($)

1b: HRB premium revenue All jurisdictions

\"\"

gross of ceded reinsurance premiums revenue ceded

OVC ($) OSHC ($)

1c. Insurance Discounts and Promotions All jurisdictions

Discounts ($) Promotions ($)

Section 2: Other Business Revenue

2a: Gross HRB revenue ‐ non‐insurance activities All jurisdictions From External Value recorded as health

Sources ($) fund benefits ($)

Optical business Dental business Hospitals and Medical Centres Agency business

2b: Net other operational revenue Amount ($) Description

Major other source: Secondary other source: Residual:

Other1

Other2

Other3

Section 3: Net Investment Income

(net of all investment expenses and fees) All jurisdictions Realised ($) Unrealised ($)

Interest rate investments Equities

Property Loans and advances Indirect investments Other

\n```\n\n![](image.008.png)\n\n```html\n

Hospital Treatment ($) Net RETF ($)

General Treatment and Ambulance ($) State Ambulance Levies ($)

1b: HRB All jurisdictions

\"\"

gross of reinsurance reinsurance recoveries recoveries

OVC ($) OSHC ($)

Section 2: Other Business Expenses

2a: All other business expenses All jurisdictions

\"\"

HRB HRB

HIB ($) Insurance ($) Other ($)

Commissions & fees Marketing and publicity Employee Costs Operations & administration Share of Corporate Overheads Other Management Expenses

Description

Costs of goods/services: Optical business

Costs of goods/services: Dental business

Costs of goods/services: Hospitals & Medical Centres

Costs of goods/services: Other

Other1

HRB HRB

2b: Claims handling expenses (recognised in Section 2a) HIB ($) Insurance ($) Other ($)

Section 3: Non‐operating Expenses

All jurisdictions ($)

Interest Expense & Other Borrowing Costs Other Expenses

Income tax expense paid or payable / (credit received or receivable)

\n```\n\n![](image.011.png)\n\n```html\n

Other1

Other2

Other3

Other4

Other5

1b: Capital distributions and transfers out

Date incurred

Description

Amount ($)

Other6

Other7

Other8

Other9

Other10

\n```\n\n![](image.012.png)\n\n```html\n

Cash Cash on hand

Demand deposits

Equities: ASX Listed

Other Australian Exchange Listed Australian Unlisted Foreign Exchange Listed Foreign Unlisted

Property

> 30 days > 90 days > 12 months

Financial instruments (other than cash and equities) Maturity: ≤ 30 days ($) ≤ 90 days ($) ≤ 12 months ($) ≤ 36 months ($) > 36 months ($)

Interest bearing assets (non‐derivative): ASX Listed

Other Australian Exchange Listed Australian Unlisted Foreign Exchange Listed Foreign Unlisted

Derivatives: Exchange Traded

Derivatives: Over The Counter

Other financial instruments

description

Other1

Section 2: Indirectly Held Assets

2a: Underlying assets on a look‐through basis ($)

Cash Cash on hand

Demand deposits

Equities: ASX Listed

Other Australian Exchange Listed Australian Unlisted Foreign Exchange Listed Foreign Unlisted

Property

> 30 days > 90 days > 12 months

Financial instruments (other than cash and equities) Maturity: ≤ 30 days ($) ≤ 90 days ($) ≤ 12 months ($) ≤ 36 months ($) > 36 months ($)

Interest bearing assets (non‐derivative): ASX Listed

Other Australian Exchange Listed Australian Unlisted Foreign Exchange Listed Foreign Unlisted

Derivatives: Exchange Traded

Derivatives: Over The Counter

Other financial instruments

description

Other2

2b: Other indirectly held assets ($)

ASX Listed fund Other

\n```\n\n![](image.013.png)\n\n```html\n

Holdings in associated and subsidiary entities HIB unclosed business (earned premium only) HRB unclosed business (earned premium only) Loans

Equipment DAC

Other intangibles (including FITB and goodwill) Pre‐paid Expenses

Receivables: from the ATO, excluding FITB

Receivables: RETF

Receivables: PHI contribution rebates

Other

description

Other1

Section 4: Counterparty Disclosure

4a: Counterparty by Type

Deposits in ADIs ($)

Grade 1 Grade 2 Grade 3 Grade 4 Unrated

Australian government counterparties ($) Overseas government counterparties ($) Australian ADIs (not including deposits in ADIs) ($) Overseas banks ($) Australian corporate or other counterparties ($) Overseas corporate or other counterparties ($)

4b: Large exposures to groups of related counterparties (excluding exposures to Australian government, or deposits with ADIs)

Uncompensated loss ($) Total exposure ($) Organisation

Largest uncompensated loss exposure Second largest uncompensated loss exposure (only where over 5% of total assets) Third largest uncompensated loss exposure (only where over 5% of total assets) Fourth largest uncompensated loss exposure (only where over 5% of total assets) Fifth largest uncompensated loss exposure (only where over 5% of total assets)

Other1

Other2

Other3

Other4

Other5

\n```\n\n![](image.016.png)![](image.015.png)![](image.014.png)\n\n```html\n

Contributions In Advance Liability Unexpired Risk Liability (CIA Component) Unexpired Risk Liability (unclosed component and constructive obligations)

Unpresented & Outstanding Claims

Benefit component Administration component RETF component OSC margin for risk

RETF Liability RETF margin for risk

Loyalty Bonus Liability Loyalty Bonus margin for risk

Other Insurance Liabilities

Section 2: Other Liabilities

Creditors and borrowings ($)

Bank overdrafts Issued loans and commercial paper Lease liabilities Creditors (trade and non‐core business unit) Other

Provisions ($)

Dividends Taxation

Employee entitlements

Amount (S) Description

Other Liabilities & Provisions Other Liabilities & Provisions

Other1

Other2

\n```\n\n![](image.017.png)\n\n```html\n

Hospital SEUs (#)

Outstanding claims liability ‐ 75th percentile ($) Future claims liability ‐ 75th percentile ($) Future claims liability with no risk margin ‐ 50th percentile ($)

Unbilled calculated deficit ($) Unbilled gross deficit ($) Billed risk equalisation trust fund liability ($)

Other liabilities:

Individual other liabilities (where balance sheet liability is ≥ 2% of total balance sheet liabilities)

Central estimate value ($)

98th percentile value ($)

Description

Total of all other individual liabilities

Other1

Other2

Other3

Other4

Collective other liabilities (where balance sheet liability is <2% of total balance sheet liabilities)

Section 4: Subordinated Debt (recognised under the Capital Adequacy Standard)

Approved loss absorbing subordinated debt ($) Previously approved subordinated debt ($)

Section 5: Supervisory Adjustments

Capital Adequacy supervisory adjustment amount Capital Adequacy supervisory adjustment amount Solvency supervisory adjustment amount

Quantum of assets test ($) Concentration of assets test ($) Liquidity test ($)

\n```\n\n![](image.019.png)![](image.018.png)\n\n```html\n

1b: Incurred value of payments and services provided to related parties

Related Party

ACN or ABN (no spaces)

Relationship to health benefits fund

Nature of Transaction

Value of Transaction ($)

1c: Outstanding obligations receivable from related parties

Related Party

ACN or ABN (no spaces)

Relationship to health benefits fund

Nature of Transaction

Fair Value of Exposure ($)

1d: Outstanding obligations payable to related parties

Related Party

ACN or ABN (no spaces)

Relationship to health benefits fund

Nature of Transaction

Fair Value of Exposure ($)

\n```\n\n![](image.020.png)\n\n```html\n

48 Months Prior

47 Months Prior

46 Months Prior

45 Months Prior

44 Months Prior

43 Months Prior

42 Months Prior

41 Months Prior

40 Months Prior

39 Months Prior

38 Months Prior

37 Months Prior

36 Months Prior

35 Months Prior

34 Months Prior

33 Months Prior

32 Months Prior

31 Months Prior

30 Months Prior

29 Months Prior

28 Months Prior

27 Months Prior

26 Months Prior

25 Months Prior

24 Months Prior

23 Months Prior

22 Months Prior

21 Months Prior

20 Months Prior

19 Months Prior

18 Months Prior

17 Months Prior

16 Months Prior

15 Months Prior

14 Months Prior

13 Months Prior

12 Months Prior

11 Months Prior

10 Months Prior

9 Months Prior

8 Months Prior

7 Months Prior

6 Months Prior

5 Months Prior

4 Months Prior

3 Months Prior

2 Months Prior

1 Month Prior

Same Month

\n```\n\nReporting Form HRF 602.0 series\n\nFinancial and Capital Data\n\nExplanatory notes\n\nThe HRF 602.0 series collects data for three main purposes:\n\n to enable APRA to compile industry statistics that are released both publicly and to the industry;\n to monitor compliance with the Capital Adequacy and Solvency Standards; and\n to enable APRA to monitor key financial risks to health insurers.\n\nThe HRF 602.0 series includes a cover page and nine other reporting forms that collect financial and capital data. These reporting forms are:\n\n HRF 602.0 Financial and Capital Data - Cover page (HRF 602.0);\n HRF 602.1 Financial and Capital Data – CA Forecasts (HRF 602.1);\n HRF 602.2 Financial and Capital Data – Solvency Forecasts (HRF 602.2);\n HRF 602.3 Financial and Capital Data - Revenue (HRF 602.3);\n HRF 602.4 Financial and Capital Data - Expenses (HRF 602.4);\n HRF 602.5 Financial and Capital Data – Capital Transfers (HRF 602.5);\n HRF 602.6 Financial and Capital Data - Assets (HRF 602.6);\n HRF 602.7 Financial and Capital Data - Liabilities (HRF 602.7);\n HRF 602.8 Financial and Capital Data – Related Party Disclosures (HRF 602.8); and\n HRF 602.9 Financial and Capital Data – Claims Data (HRF 602.9).\n\nThe HRF 602.0 series has been designed to collect enough information to form a Profit and Loss statement and a Balance Sheet. In particular, data recorded in HRF 602.3, HRF 602.4 and HRF 602.5 must fully reconcile with any movements in the HRF 602.6 and HRF 602.7 from the previous submission.\n\nHRF 602.1 and HRF 602.2 enable APRA to determine if the health insurer has complied with the rules and prudential standards.\n\nThe remaining reporting forms (HRF 602.8 and HRF 602.9) give additional risk information.\n\nNo explicit sign-off is necessary, as the submission itself will be treated as constituting sign-off.\n\nBroad structure of HRF 602.0 series\n\nThe HRF 602.0 series reporting forms are presented as an Excel file or XML-coded template. The Excel template contains specific cell placements and the XML template specific line structure which record data. There must be no locks or passwords over the cells, structure or template. Health insurers must not amend the structure (e.g. row or column insertion) or format (e.g. changing format to Excel Binary being \\*.xlsb) of the Excel file of XML template.\n\nWithin each reporting form of the HRF 602.0 series are Sections. Specific details on the purpose of each Section are outlined in these reporting instructions.\n\nIn columns where text descriptions are required, entries of the form ‘OtherX’ have been inserted into the template. As a default, these should be left unaltered, even where there are no corresponding entries in the same row.\n\nBasis of reporting\n\nHRF 602.1, HRF 602.3, HRF 602.4, HRF 602.5 and HRF 602.8 must all be completed on an incurred basis.\n\nHRF 602.2 and HRF 602.9 must be completed on a cash flow basis.\n\nIn accordance with the Rules and unless indicated otherwise, any amount or value that is required in the completion of the HRF 602.0 series must be calculated in accordance with the accounting standards as issued by the Australian Accounting Standards Board, including but not limited to AASB 124, AASB 137, AASB 139, and AASB 1023.\n\nUnits of measurement\n\nAll financial values, quantities and percentages must be reported to no more than two decimal places.\n\nFinancial values must be reported in Australian dollars.\n\nUnless specified otherwise, the format of date input must be dd/mm/yyyy (e.g. 31/03/2014).\n\nHRF 602.0 Financial and Capital Data – Cover Page\n\nExplanatory Notes\n\nPurpose\n\nHRF 602.0 collects details about the health benefits fund and the period to which the submission relates.\n\nInstructions for specific items\n\nData required\n\n| Term | Instruction/comment |\n| --------------- | -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- |\n| Period ended | The date at the end of the period for which the return reports on. Must be in mmm-yy date format (e.g. Mar-14). |\n| Period length | Must be either option:QuarterlyAnnual |\n| Contact details | These details should provide APRA with the best contact if there are any queries with respect to the information provided in the return.The contact person need not be an Officer of the private health insurer, but should be knowledgeable in the contents of the return and available to be contacted by APRA following submission. |\n\nHRF 602.1 Financial and Capital Data – CA Forecasts\n\nExplanatory Notes\n\nThis reporting form consists of two Sections:\n\n Section 1: Central estimates; and\n Section 2: Stressed estimates.\n\nPurpose\n\nThe primary purpose for this reporting form is to provide APRA with the data necessary to calculate the stress test amount in Prudential Standard HPS 110 Capital Adequacy (HPS 110). As such, all of the terms in the HPS 110 for the stress test amount are calculable from the values entered in this reporting form (see below).\n\nThe disclosure in this reporting form also gives important information on insurance risk in the health benefits fund. For example, changes in growth can lead to significant changes in the risk profile of a health insurer, as well as being known to significantly impact gross margins because of the impact from waiting periods. As such, the forecasts relating to new and terminated policies in Section 1 can provide important information about potential changes to underwriting margins and insurance risk.\n\nSimilarly, some central estimate forecasts and the reporting of forecasts at each month during the next 12 month period are not directly needed to assess compliance with HPS 110. They do, however, provide important contextual information on the nature of the stress test amount: how it might play out over the period, and how different to central estimate outcomes it could be.\n\nInstructions for specific items\n\nSection 1: Central Estimates\n\n| Term | Instruction/comment |\n| -------------------------------------------------------------------- | ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- |\n| Central estimate | This means an estimate of the mean of the range of possible outcomes. The health insurer must choose its own methodology, assumptions and data in order to determine the central estimates. |\n| Next/2nd/3rd/4th quarter in the future | Central estimate forecasts in the first table must be provided for each of the next four quarters starting from the reporting date. |\n| New HIB policy | A new Health Insurance Business (HIB) policy, in force at the end of the quarter, where none of the policy holders held a policy with the health insurer at the start of the quarter. |\n| New HIB policy, transfers | A new HIB policy where at least one policy holder of a policy would be expected to have a transfer certificate. |\n| New HIB policy, new to PHI | A new HIB policy which is not a 'new HIB policy, transfers'. |\n| Terminated policies | The number of policies given by the equation:= [Policies in force at start of quarter] - [Polices in force at end of quarter] + [New policies]Where possible, actuals are to be used as a start point when calculating terminated policies for the next quarter in the future. For subsequent quarters, forecasts for the start and end of that quarter are to be used. |\n| Average monthly premium rate | For new policies, this is the average premium rate for those policies at the points in the forecast quarter where they first become in force.For terminated policies, this is the average premium rate for those policies immediately before the points in the forecast quarter where they first stop being in force. |\n| Months 1 to 12 | Central estimate forecasts in the second table must be provided for each of the next 12 months starting from the reporting date. |\n| Hospital SEUs | These are single equivalent units (SEUs) as defined inPart 1, Rule 4 of the Private Health Insurance (Risk Equalisation Policy) Rules 2007. Persons with general treatment only do not contribute to the total hospital SEUs. |\n| HIB Premium increase assumed… | The calculation of the HIB premium increase must be consistent with the pricing methodology prescribed in the approved form under section 66-10 of the Private Health Insurance Act 2007 (PHI Act). Currently, this formula is:(FCI with premium changes – FCI without premium changes) / FCI without premium changeswhere FCI is the forecast contribution income for the health insurer for the 12 month period following the implementation of the changes, excluding forecast changes in membership, and excluding rate protection.Enter the assumed premium increase that would apply in the relevant month after the projection date (and only enter it in that month). |\n| …given the STAC | The Stress Test Assumptions Constraint (STAC) is 'determined in accordance with the methodology published by APRA, as amended from time to time' (taken from the definition of premium income estimate in HPS 110). |\n| HIB Contribution income, given premium increase subject to the STAC | This row should sum to the premium income estimate (as defined in HPS 110). |\n| HRB Income | This is a central estimate of the gross revenue earned by the health benefits fund in relation to its health-related business (HRB).This row, plus the HIB Contribution income, given premium increase subject to the STAC row, should sum to the health business revenue estimate (as defined in Prudential Standard HPS 001 Definitions (HPS 001)). |\n| Margin (HIB Gross, HIB Net, Investment Income, HRB and other income) | These are all measures of profit, in the relevant month, as a percentage of HIB Contribution income, given premium increase subject to the STAC, in that month. |\n\nSection 2: Stressed estimates\n\n| Term | Instruction/comment |\n| ----------------------------------- | --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- |\n| Xth percentile | This is the xth percentile (as defined in the Rules) and must be less than 50 per cent. Health insurers should exercise care to ensure the wrong side of the distribution is not selected. |\n| HIB Net margin (%) | This is the monthly margin (as a percentage of HIB Contribution income, given premium increase subject to the STAC) that achieves NM% over the year. |\n| NM% | This quantity is defined in the definition of stressed net margin estimate in HPS 110. |\n| Investment income margin (%) | This is the monthly margin (as a percentage of HIB Contribution income, given premium increase subject to the STAC) that achieves the stressed investment income estimate (as defined in HPS 110) over the year. |\n| Stressed Investment Income Estimate | This is the stressed investment income estimate as defined in HPS 110. Note that a negative value must be entered where stressed losses are expected. |\n| HRB and other income margin (%) | This is the monthly margin (as a percentage of HIB Contribution income, given premium increase subject to the STAC) that achieves the stressed other income estimate (as defined in HPS 110) over the year. |\n| Stressed Other Income Estimate | This is the quantity stressed other income estimate as defined in HPS 110. Note that a negative value must be entered where stressed losses are expected. |\n| Tax (%) | This is the monthly tax payment (as a percentage of HIB Contribution income, given premium increase subject to the STAC) that achieves the Tax ($). It is not the tax rate (currently 30 per cent for for-profit insurers). |\n| Tax ($) | This is the quantity T defined in the definition of stress test amount in HPS 110. Note that a negative value must be entered where tax credits resulting from stressed losses are expected. |\n\nNote that, to verify that values have been reported with the correct sign, the stress test amount in HPS 110 must be the sum of:\n\n the negative of the stressed net margin estimate;\n the negative of the stressed investment income estimate;\n the negative of the stressed other income estimate; and\n T (tax).\n\nHRF 602.2 Financial and Capital Data – Solvency Forecasts\n\nThis reporting form consists of only one Section, the cash flow projections.\n\nPurpose\n\nThe primary purpose for this reporting form is to provide APRA with the data necessary to calculate the cash management amount under Prudential Standard HPS 100 Solvency Standard (HPS 100).\n\nThe other information contained in this reporting form gives important information on liquidity risk in the health benefits fund. The central estimate forecasts of cash flows in the next 30 days put the stressed net cash outflow in context, and the projections out to 90 days give an indication of likely compliance with HPS 100 until the next reporting date.\n\nIn contrast to reporting forms HRF 602.3, HRF 602.4 and HRF 602.5 (which are on an earned/incurred basis), this reporting form is on a cash flow basis.\n\nInstructions for specific items\n\nSection 1: Cash flow projections\n\n| Term | Instruction/comment |\n| ---------------------------------- | --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- |\n| Central estimate net cash outflows | These forecasts must relate to cash flows as committed on the reporting date. Discretionary cash flows are any cash flow where no binding agreement for the sale/transfer has been made. This may therefore include expected or unannounced dividend payments and cash flows resulting from the sale or purchase of assets. |\n| Stressed Net Cash Outflow Amount | This is the stressed net cash outflow amount as defined in HPS 100. |\n\nHRF 602.3 Financial and Capital Data – Revenue\n\nExplanatory Notes\n\nContent\n\nThe Revenue worksheet consists of three Sections:\n\n Section 1: Insurance Revenue;\n Section 2: Other Business Revenue; and\n Section 3: Net Investment Income.\n\nPurpose\n\nThis reporting form contains details of revenue and income of the health benefits fund with segregation between key areas. Its primary purpose is to provide APRA with revenue data.\n\nIn addition, data on discounts and promotions provides important information for APRA to understand the risks to insurance premiums.\n\nThe revenue worksheet provides data necessary for compiling a Profit and Loss statement. In particular, when combined with data collected in HRF 602.4 and HRF 602.5, it can reconcile the changes in the Balance Sheet (data collected in HRF 602.6 and HRF 602.7) since the previous submission.\n\nHIB premium revenue\n\nThe sum of the values in Section 1a will give the total HIB premium revenue during the relevant reporting period.\n\nSections which do not contribute towards total fund revenue\n\nSection 1c (discounts and promotions) does not contribute towards the total fund revenue (which is reported net of these values), and nor do the descriptions in Section 2b.\n\nColumn E of Section 2 (HRB non-insurance revenue record as health fund benefits) does not contribute towards total fund revenue since it is an intra-fund transfer.\n\nInstructions for specific items\n\nSection 1: Insurance Revenue\n\n| Term | Instruction/comment |\n| ----------------------------------------------------------- | ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- |\n| Revenue | The recognition criteria of AASB 1023 (and AASB 139 where appropriate) are to be applied for the purpose of attributing revenue amounts to this reporting form (i.e. revenue must be determined by application of the relevant Australian accounting standards). |\n| HIB premium revenue | As per AASB 1023, this means the premium payable by the policy holder, and is net of discounts and promotions, but gross of any commissions/fees taken by intermediaries. |\n| Split by state or territory | This is based on the principal place of residence of the insured persons. |\n| Split by hospital treatment/general treatment and ambulance | Premium must be split by services covered. For example, premium revenues on products termed ‘hospital only’, but that offer elements of general treatment, must be apportioned appropriately between the two categories.Hospital treatment and general treatment are defined under sections 121-5 and 121-10 of the Private Health Insurance Act 2007 respectively. |\n| HRB premium revenue | HRB premium revenue is premium revenue earned from non-HIB insurance activities and within the meaning of HRB as defined under section 131-15 of the Private Health Insurance Act 2007.In column D, HRB premium revenues must be gross of:any reinsurance arrangements whereby premium is ceded to a reinsurer; andbrokerage fees or commissions paid in respect of policies covered. |\n| OVC | Premium revenue earned for overseas visitors cover (OVC) is the total HRB premium revenue earned less any overseas student health cover (OSHC) premium revenue earned.It must equal the premiums earned from certain overseas visitors and specified temporary visa holder health insurance contracts as defined in the Private Health Insurance (Health Insurance Business) Rules 2013. |\n| OSHC | Premium revenue earned for overseas students health insurance contracts, as defined in the Private Health Insurance (Health Insurance Business) Rules 2013. |\n| Discount | The value of the effects on the earned HIB premium (as recognised in Section 1a by discounts which are intended to be offered on an ongoing basis and/or to persons who have already purchased a policy. An example would be offering a discount for all policy holders paying electronically.These discounts must comply with the Private Health Insurance (Complying Product) Rules 2010. |\n| Promotion | The value of the effects on the earned HIB premium (as recognised in Section 1a by promotions which are offered to a person at the time the person first purchases a policy. An example would be offering a free period of cover to a new member.These promotions must comply with the Private Health Insurance (Complying Product) Rules 2010. |\n\nSection 2: Other Business Revenue\n\n| Term | Instruction/comment |\n| -------------------------------------- | -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- |\n| From external sources | This means all HRB non-insurance revenue that is earned from outside the health benefits fund. It therefore includes:revenue from non-policy holders of the health benefits fund;revenue to cover services provided by the health benefits fund; andrevenue from policy holders of the health benefits fund for services not covered by the insurance premium. |\n| Value recorded as health fund benefits | This is the value of providing services to policy holders of the health benefits fund that are covered by their insurance premiums.Since this amount does not involve the policy holders paying the fund a second time, it is excluded when calculating total fund revenue. Note that, however, it is needed when calculating total fund expenses (see below). |\n| Agency business | Revenues related to agency business are included as HRB.An agency business is defined under the Private Health Insurance (Health Benefits Fund Policy) Rules 2007. |\n| Net other operational revenue | This means all other (i.e. other than HIB and HRB) operational revenue, net of expenses, attributable to the fund.Note that the expenses by which this amount is netted must not also occur in Section 3 of HRF 602.4. |\n\nSection 3: Net Investment Income\n\n| Term | Instruction/comment |\n| --------------------- | ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ |\n| Net investment income | This includes investment income and changes in investment asset values (both from revaluation and from market movements).Where income is negative, enter a negative value.Income must be recorded net of all investment expenses and fees. |\n\nHRF 602.4 Financial and Capital Data – Expenses\n\nExplanatory Notes\n\nThe Expenses worksheet consists of three Sections:\n\n Section 1: Insurance Claims;\n Section 2: Other Business Expenses; and\n Section 3: Non-operating Expenses.\n\nPurpose\n\nThis reporting form contains details of benefits and expenses of the health benefits fund with segregation between key areas.\n\nIts primary purpose is to provide APRA with expense data.\n\nIt provides data necessary for compiling a Profit and Loss statement. In particular, when combined with data collected in HRF 602.3 and HRF 602.5, it can reconcile the changes in the Balance Sheet (data collected in the HRF 602.6 and HRF 602.7) since the previous submission.\n\nTotal HIB benefits (for gross margin purposes)\n\nThe sum of the values in Section 1a will give the total HIB benefits during the relevant reporting period used to produce the gross margins.\n\nTotal HIB expenses (for net margin purposes)\n\nThe sum of the values in Column D of Section 2a (HIB all other business expenses) will give the total HIB expenses during the relevant reporting period used to produce the net margins.\n\nSections which do not contribute towards total fund expenses\n\nSection 2b (claims handling expenses) does not contribute towards the total fund expenses (being already reflected in the other business expenses in Section 2a), and nor does the description in Section 2a.\n\nInstructions for specific items\n\nSection 1: Insurance Claims\n\nMovements in the benefit component of the outstanding claims and unexpired risk liabilities are to be reported at the relevant Hospital treatment or General treatment and Ambulance. This would include the application of a risk margin for the benefit component of the outstanding claims liability.\n\nMovement in the Risk Equalisation Trust Fund (RETF) component of the outstanding claims liability is to be reported at the net RETF item. This may include the application of a risk margin.\n\nMovement in the administration component of the outstanding claims liability is to be included in the claims handling expenses item, as well as allocated in Section 2.\n\n| Term | Instruction/comment |\n| ---------------------------------------------------------------------------------------- | -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- |\n| HIB claims | These are the value of all HIB benefits incurred, including the value of services provided in lieu of a benefit payment. |\n| Split by hospital treatment, general treatment and ambulance, and state ambulance levies | HIB claims must be split by services covered. For example, claims for general treatment services on products termed ‘hospital only’ must be apportioned to general treatment and ambulance.Hospital treatment and general treatment are defined under sections 121-5 and 121-10 of the Private Health Insurance Act 2007 respectively. |\n| Net RETF | Enter a negative value where RETF is a net receipt in that jurisdiction.Although NSW and ACT are in the same RETF jurisdiction, the total net RETF in that jurisdiction should be apportioned between NSW and ACT according to the split of the residency of the health benefit fund’s hospital SEUs as at the reporting date. |\n\nSection 2: Other Business Expenses\n\n| Term | Instruction/comment |\n| ---------------------------- | ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- |\n| Commissions & Fees | Fees and/or commissions paid to agents, brokers or aggregators. |\n| Employee Costs | Includes recruitment, residual salary, wages, contractor and on costs, training etc. |\n| Cost of goods/services | These are the costs of all goods and/or services provided to both policy holders and non-policy holders of the health benefits fund.Because HIB claims (Section 1a) includes the value of services provided in lieu of a benefit payment, some costs of goods/services will be reflected in both Section 1a and in Section 2a. As such, the total value of these double-counted costs (which is reported in Column E of Section 2a in the Revenue worksheet) must be deducted from Section 2a when calculating total fund expenses. |\n| Marketing and publicity | Includes, for example, publications, advertising, sponsorship, publicity, health maintenance and promotion programmes. |\n| Operations & administration | Includes, for example, self-occupied property expenses, IT and computing, postage, telephones, accounting audit and other professional feed and membership subscriptions. |\n| Share of corporate overheads | Overhead expenses of another entity borne by the Fund. |\n| Claims handling expenses | Note that the costs associated with processing a claim are a subset of those already recorded in Section 2a. |\n\nSection 3: Non-operating expenses\n\n| Term | Instruction/comment |\n| ---------------------------------------- | ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- |\n| Non-operating expenses | To avoid double counting, expenses already recognised in netting off Revenue in Section 3 of HRF 602.3 must be excluded. |\n| Interest Expense & Other Borrowing costs | The definition, recognition and measurement of borrowing costs must be in accordance with AASB 123. |\n| Other expenses | These cover all other items of expense to the health benefits fund not otherwise reported (noting the requirement that reporting forms HRF 602.3, HRF 602.4 and HRF 602.5 be fully able to explain changes in the HRF 602.6 and HRF 602.7). |\n| Income Tax expense paid or payable | The amount of income tax paid or payable from the health benefits fund (whether or not the liability for tax stems from the operations of the health benefits fund) is reported at this item. |\n\nHRF 602.5 Financial and Capital Data – Capital Transfers\n\nExplanatory Notes\n\nThis reporting form provides the remaining relevant data in order to explain movements in the Balance Sheet since the previous reporting period.\n\nAs per HRF 602.3 and HRF 602.4, it must be completed on an incurred basis.\n\nData required\n\n| Term | Instruction/comment |\n| --------------------------------------- | ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- |\n| Capital transfers in | These include all events that result in increased capital in the health benefits fund that are not otherwise recorded in HRF 602.3 and HRF 602.4. As such they could include but are not limited to:capital injections through issuing of shares;capital injections from a parent entity;gifts to the health benefits fund; andasset revaluation reserve for non-investable assets.Where more than five transfers are incurred in the period, those smaller than the largest four must be combined into row 10, and the date incurred can be omitted. The description should attempt to cover the nature of these transfers collectively. |\n| Capital distributions and transfers out | These include all events that result in reduced capital in the health benefits fund that are not otherwise recorded in HRF 602.3 and HRF 602.4. As such they could include but are not limited to:dividend payments;capital transfers to a parent or subsidiary entity;donations made by the health benefits fund; andasset revaluation reserve for non-investable assets.Where more than five events are incurred in the period, those smaller than the largest four must be combined into row 17, and the date incurred can be omitted. The description should attempt to cover the nature of these events collectively. |\n\nHRF 602.6 Financial and Capital Data – Assets\n\nExplanatory Notes\n\nThis reporting form consists of four Sections:\n\n Section 1: Directly Held Assets;\n Section 2: Indirectly Held Assets;\n Section 3: Other Assets; and\n Section 4: Counterparty Disclosure.\n\nPurpose\n\nThis worksheet collects Balance Sheet information on the health benefits fund that is necessary to monitor compliance with HPS 100 and HPS 110.\n\nIn particular:\n\n the total health benefits fund assets is required for assessing compliance with HPS 110;\n the capital adequacy maximum default loss amount is the value entered in cell D84; and\n cash (the sum of the values in cells D7 and D8) is required for assessing compliance with HPS 100.\n\nThe splits of assets by various risk categories give important information on the riskiness of assets in the health benefits fund.\n\nTotal fund assets\n\nThe sum of the values in Sections 1, 2 and 3 will give the total value of assets in the health benefits fund. This value of assets is used in assessing compliance with HPS 110.\n\nThe values in Sections 4a and 4b refer to a subset of the same assets already apportioned in Sections 1, 2 and 3, and give a different apportionment of those assets.\n\nInstructions for specific items\n\nSection 1: Directly held assets\n\nThis Section refers to directly held financial instruments and property.\n\n| Term | Instruction/comment |\n| ----------------------- | --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- |\n| Cash on hand | Physical notes and coins held on site. |\n| Demand deposits | At call (i.e. withdrawal without notice) money held with a third party. |\n| Equities | These include listed and unlisted shares held directly.They do not include:options, futures and other derivatives that relate directly to equities (these must be recorded as direct derivatives); andholdings in associated and subsidiary entities (which are included in Section 3). |\n| Interest bearing assets | These should be reporting according to whether the asset itself is listed. For example, a corporate bond listed on the ASX would be reported as ASX listed, but a term deposit held in an ADI would be reported as Australian Unlisted (even if equities in the ADI are listed). |\n| Maturity | The term to maturity, in days/months as appropriate, as at the end of the reporting period. Where financial instruments have no defined maturity date and are perpetual in nature, include within the '≤ 30 days' column. |\n\nSection 2: Indirectly held assets\n\nThis Section refers to indirectly held financial instruments and property.\n\nWhere health insurers have applied the ‘look-through’ approach to indirect investments, the underlying assets should be apportioned appropriately in Section 2a.\n\nThe remaining indirect investments must then be apportioned in Section 2b. Note that APRA expects that a significant level of risk is attached to any assets in this section and may require further information on their content.\n\n| Term | Instruction/comment |\n| -------- | ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ |\n| Equities | These include listed and unlisted shares held in managed equity funds (including private equity funds) or the equity component of a managed fund.They do not include:options, futures and other derivatives in managed funds that relate directly to equities (these must be recorded as indirect derivatives);property trusts (these must be recorded as indirect property); andholdings in associated and subsidiary entities (which are included in Section 3). |\n| Maturity | The term to maturity, in days/months as appropriate, at the end of the reporting period.Where financial instruments have no defined maturity date and are perpetual in nature, include within the '≤ 30 days' column. |\n\nSection 3: Other assets\n\nAll remaining assets, having completed Sections 1 and 2, must be entered in this Section.\n\n| Term | Instruction/comment |\n| ---------------------------------------------- | ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- |\n| Holdings in associated and subsidiary entities | Where the valuation methodology applied to the investment in an associate or subsidiary entity of the health benefits fund is anything other than fair value, the value of the net tangible assets of the subsidiary may be used as the investment’s prescribed value for the purpose of completing the reporting form.This applies even when the value of the net tangible assets exceeds the book value of the entity in the Corporations Act 2001 accounts of the Insurer. |\n| DAC | Deferred acquisition costs (DAC) are to be reported separately from the other intangibles (in cell D62). |\n| Unclosed business | Unclosed business is disclosed separately for the health insurance and the health-related insurance business of the Fund.Only earned unclosed business contributions are recognised. These are premiums in arrears, including those collected by third parties, measured up to the Balance Sheet date only.Unearned contributions on unclosed business (i.e. forecasted premiums receivable from the Balance Sheet date to the expiry of the contract period in respect of current health insurance contracts) are no longer recognised as an asset (and there is no corresponding liability). |\n| Equipment | This must be recorded net of depreciation and amortisation. It includes but is not limited to fixtures and fittings, computer hardware, and motor vehicles. |\n\nSection 4: Counterparty disclosure\n\n| Term | Instruction/comment |\n| -------------------------------------------- | -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- |\n| ADI | For the full list of Authorised Deposit-taking Institutions (ADIs), please visit APRA’s website.This may include demand deposits noted in Sections 1 and 2 if the money is held in an ADI.The counterparty should be the ultimate issuer of the product and not the 'brand name' that the product is issued under. The Product Disclosure Statement, or similar documents, should provide the name of the counterparty. |\n| Grade 1, Grade 2, Grade 3, Grade 4, unrated. | These refer to the counterparty grade as described in the table below.Where there is conflict between two ratings (e.g. between those given by different ratings agencies, or between those in the long-term and short-term ratings table), the lowest grade is applied.Where an agency rates an asset, but only as being below a certain level, it must be categorised as Grade 4.Where there is no rating, for whatever reason, the asset value must be included in the unrated column. |\n| Largest uncompensated loss exposure | The amount entered in cell D84 must equal the capital adequacy maximum default loss amount as defined in HPS 110. |\n| Uncompensated loss exposures | These must be calculated consistent with the definition of capital adequacy maximum default loss in HPS 110. As such, they must be on a look-through basis, and must exclude exposures to Australian Government counterparties and deposits in ADIs. Note that they may, for example, include parties related to the health benefits fund.Where the exposures are uncertain (e.g. due to opaque indirect investments), prudent estimates of these quantities may be entered (noting the materiality limit enforced in the definition of capital adequacy maximum default loss amount). |\n\nLong-term ratings:\n\n```html\n

Grade

Standard & Poor's

Moody's

AM Best

Fitch

Debt

FSR

1

AAA

Aaa

aaa

A++

AAA

AA+

Aa1

aa+

A+

AA+

AA

Aa2

aa

AA

AA-

Aa3

aa-

AA-

2

A+

A1

a+

A

A+

A

A2

a

A

A-

A3

a-

A-

A-

BBB+

Baa1

bbb+

B++

BBB+

BBB

Baa2

bbb

BBB

BBB-

Baa3

bbb-

B+

BBB-

3

BB+

Ba1

bb+

B

BB+

BB

Ba2

bb

BB

BB-

Ba3

bb-

B-

BB-

B+

B1

b+

C++, C+

B+

B

B2

b

C

B

B-

B3

b-

C-

B-

4

Below B-

Below B3

Below b-

Below C-

Below B-

\n```\n\n \nShort-term ratings:\n\n```html\n

Grade

Standard & Poor's

Moody's

AM Best

Fitch

1

A1+

P1

AMB-1+

F1+

A1

AMB-1

F1

2

A2

P2

AMB-2

F2

A3

P3

AMB-3

F3

3

B

NP Vulnerable

AMB-4

B

4

C

NP Currently Vulnerable

C

\n```\n\nHRF 602.7 Financial and Capital Data – Liabilities\n\nExplanatory Notes\n\nThis reporting form consists of five Sections:\n\n Section 1: Insurance Liabilities;\n Section 2: Other Liabilities;\n Section 3: Prudent Liabilities (HPS 110);\n Section 4: Subordinated Debt (recognised under HPS 110); and\n Section 5: Supervisory Adjustments.\n\nPurpose\n\nThis reporting form collects Balance Sheet information to monitor compliance with HPS 100 and HPS 110.\n\nTotal fund liabilities\n\nThe sum of the values in Sections 1 and 2 should give the total value of liabilities in the health benefits fund, measured in accordance with the relevant AASB Standards.\n\nLiabilities for HPS 110\n\nSections 3, 4 and 5 relate to the same liabilities as those reported in Sections 1 and 2, but measured in accordance with HPS 110 (rather than in accordance with AASB Standards).\n\nInstructions for specific items\n\nSection 1: Insurance Liabilities\n\nThe insurance liabilities of the health benefits fund are disclosed separately for HIB and HRB. Each must be measured in accordance with the relevant AASB Standards.\n\n| Term | Instruction/comment |\n| -------------------------------------------------------------------------- | ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- |\n| Unearned Premium & Unexpired Risk Liability | These liabilities include both liabilities related to closed business and unclosed business. |\n| Contributions in Advance Liability | The Contributions in Advance (CIA) liability is the amount of premium revenues actually received prior to the valuation date for insurance cover to be provided for periods after the valuation date. It relates to closed business only. |\n| Unexpired Risk Liability (CIA component) | Amount calculated in accordance with AASB 1023 in relation to the CIA component (i.e. loss recognition in respect of unexpired risk portion of health insurance contracts current at the Balance Sheet date). It also relates to closed business only. |\n| Unexpired Risk Liability (unclosed component and constructive obligations) | Amount calculated in accordance with AASB 1023 as the sum of:the amount in relation to the unclosed business liability component (i.e. loss recognition in respect of contracts with risk periods incepting after the Balance Sheet date, covering the period up to the contract renewal date); andthe renewal option liability component (i.e. loss recognition in respect of contracts expected to renew after the Balance Sheet date, covering the period up to the date of the next expected pricing review).Note that the unclosed business contributions liabilities have been removed (as well as the corresponding assets). These were the amounts of unclosed business premiums in arrears for the period between the Balance Sheet date and the contract end. |\n| Unpresented & Outstanding Claims (benefit component) | Benefits payable for:claims that have been reported, but are not yet settled at balance date;claims that have been incurred, but not yet reported;claims that have been administratively settled, but which may be reopened; andany other unpaid claims including those that have been processed but not actually paid. These items should be disclosed as unpresented and outstanding claims instead of current liabilities or trade creditors. |\n| Unpresented & Outstanding Claims (administration component) | Allowance for claims handling expenses associated with those claims included within the provision for unpresented and outstanding claims. |\n| Unpresented & Outstanding Claims (RETF component) | The value of any amount payable or receivable under the RETF arrangements arising from run-off of claims included within the provision for unpresented and outstanding claims. |\n| Unpresented & Outstanding Claims (OSC margin for risk) | Dollar value of the risk margin applied to the OSC liability. |\n| RETF Liability | Amounts unpaid at balance date arising from the operation of the RETF arrangements. |\n| RETF Margin for Risk | If the health insurer has determined that a risk margin is held in relation to the RETF liability, the dollar value of the risk margin is to be reported. |\n| Loyalty Bonus Liability | The value of accrued loyalty bonus entitlements is to be reported here. |\n| Loyalty Bonus Margin for Risk | If the health insurer has determined that a risk margin is held in relation to the loyalty bonus liability, the dollar value of the risk margin is to be reported. |\n\nSection 2: Other Liabilities\n\nThe values of other non-insurance liabilities must be entered in this Section, valued in accordance with the relevant AASB Standard.\n\n| Term | Instruction/comment |\n| -------------------------------- | ---------------------------------------------------------------------------------------------------------------------- |\n| Other liabilities and provisions | All liabilities and provisions that have not otherwise been included in Sections 1 or 2 must be entered in these rows. |\n\nSection 3: Prudent Liabilities (HPS 110)\n\nMost of the quantities in this Section are necessary for determining the prudent liabilities amount in HPS 110. Those that are not, provide valuable information on methodologies for calculating compliance.\n\n| Term | Instruction/comment |\n| ------------------------------------------------------------- | ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- |\n| Hospital SEUs | This is the number of hospital SEUs as at the end of the reporting period. It is used to determine the size margin (used to determine the future claims liability amount and the outstanding claims liability amount). |\n| Outstanding claims liability – 75th percentile | The outstanding claims liability is as defined in HPS 110, that includes a risk margin to produce a 75 per cent probability of adequacy.As with the Balance Sheet liability, the outstanding claims liability should include any unpaid claims including those that have been processed but not actually paid. |\n| Future claims liability – 75th percentile | The future claims liability is as defined in HPS 110, that includes a risk margin to produce a 75 per cent probability of adequacy. |\n| Future claims liability with no risk margin – 50th percentile | This quantity is calculated using the same methodology as the future claims liability, but with no risk margin applied. |\n| Unbilled calculated deficit | This quantity is as defined in HPS 110, and is used in calculating the risk equalisation trust fund accrued liability amount. This should not be left blank. |\n| Unbilled gross deficit | This quantity is as defined in HPS 110, and is used in calculating the risk equalisation trust fund accrued liability amount. |\n| Billed risk equalisation trust fund liability | This quantity is as defined in HPS 110, and is used in calculating the risk equalisation trust fund accrued liability amount.Note that, as at a reporting date relating to a quarter end, this quantity will normally be zero given that an invoice from APRA has yet to be issued. |\n| Individual other liabilities | These represent the larger liabilities (at least 2 per cent of Balance Sheet liabilities) that form part of the other liabilities amount. They must be valued individually both at the 50th percentile (central estimate) and the 98th percentile (which is the value that contributes to the other liabilities amount).The largest four such liabilities are entered into rows 60 to 63.The remaining such liabilities are summed and entered into rows 64. That is, cell D64 is NOT the sum of D60 to D63.As section 3 is a restatement of the balance sheet, this should not be left blank if the health fund has ‘other liabilities’ noted in sections 1 and 2. |\n| Collective other liabilities | These represent the smaller liabilities (less than 2 per cent of Balance Sheet liabilities) that form part of the other liabilities amount. They must be valued collectively both at the 50th percentile (central estimate) and the 98th percentile (which is the value that contributes to the other liabilities amount).They are distinct from the individual other liabilities. |\n\nSection 4: Subordinated Debt (recognised under HPS 110)\n\n| Term | Instruction/comment |\n| ----------------------------------------- | ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- |\n| Approved loss absorbing subordinated debt | This quantity is as defined in HPS 110, and is used in calculating the subordinated debt.Note that APRA approval is required for the liability to be considered to be ‘approved loss absorbing subordinated debt’ for the purposes of HPS 110. |\n| Previously approved subordinated debt | This quantity is as defined in HPS 110, and is used in calculating the subordinated debt. |\n\nBoth of the values are for Capital Adequacy purposes. Any further subordinated debt issued by the fund that does not contribute to the definition of subordinated debt in HPS 110 must not be included in these quantities.\n\nSection 5: Supervisory Adjustments\n\nThe amount, factor, figure or methodologies for the supervisory adjustments will be prescribed by APRA to the health insurer in writing when necessary. In all other circumstances, zero is entered.\n\nHRF 602.8 Financial and Capital Data – Related Party Disclosures\n\nExplanatory Notes\n\nThis reporting form does not contribute further to the production of either a Profit and Loss statement, or to the production of a Balance Sheet.\n\nIt instead provides important information on potential contagion risks that may affect the health benefits fund arising from related parties (such as a parent insurer or other company within the same group).\n\nInstructions for specific items\n\nData required\n\n| Term | Instruction/comment |\n| ------------------------------------ | ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- |\n| Related party | A party related to the health benefits fund, as defined in AASB 124. |\n| ACN or ABN | Input number only, with no spaces (numeric field). |\n| Relationship to health benefits fund | A brief description, consistent with the definition in AASB 124, of the nature of the relationship between the related party and the health benefits fund. Examples could include but not limited to: subsidiary; parent; joint venture. |\n| Nature of transaction | A brief description of the type of goods and/or services provided to or by the related party. |\n\nHRF 602.9 Financial and Capital Data – Claims data\n\nExplanatory Notes\n\nThis reporting form is critical to APRA’s capacity to upload the data onto our system. Health insurers must ensure that the reporting form has not been tampered with and that the integrity of the default links has been maintained.\n\nThis reporting form does not contribute further to the production of either a Profit and Loss statement, or to the production of a Balance Sheet.\n\nIt instead provides important information on the nature of the risks in the outstanding claims liabilities.\n\nInstructions for specific items\n\nData required\n\n| Term | Instruction/comment |\n| ------------- | ------------------------------------------------------------------------------------------------ |\n| Claim payment | The benefit paid to the policy holder (gross of risk equalisation trust fund payments/receipts). |\n\n---\n\n[\\[1\\]](#_ftnref1) For the avoidance of doubt, if the due date for a particular reporting period falls on a day other than a usual business day, a private health insurer is nonetheless required to submit the information required no later than the due date.","sortOrder":0}],"analysis":{"kimi_summary":{"_metrics":{"model":"kimi-k2.5","source":"moonshot-realtime","completionTokens":1817},"content_quality":"ok","complexity_score":7,"scope_assessment":{"changed":true,"description":"This determination introduced a comprehensive new reporting regime when APRA assumed prudential supervision of private health insurance from PHIAC in 2015. It replaced the previous PHIAC 2 return with the extensive HRF 602.0 series of forms, significantly expanding the granularity of financial, capital, and claims data required for prudential supervision."},"complexity_factors":["Technical financial terminology requiring actuarial/accounting expertise (solvency margins, capital adequacy, risk margins, unexpired risk liability)","Multiple interconnected forms (10 separate HRF 602.x forms covering distinct aspects of financial operations)","Cross-references to external prudential standards (HPS 001 Definitions) and transitional provisions from the old PHIAC regime","Conditional requirements allowing APRA discretion to vary reporting periods and due dates","Mandatory audit requirements with specific opinion standards and follow-up obligations for qualified reports"],"plain_english_summary":"This standard requires all private health insurers to report detailed capital, financial, claims and related‑party data to APRA to support prudential supervision. Reports include solvency forecasts and audited annual statements, with quarterly returns due within 28 days of each quarter end and audited annual submissions by 30 September, lodged electronically as directed.\n\nBoards and senior management must ensure data quality and obtain external auditor certification for annual filings; APRA may vary deadlines or content for individual insurers."}},"importantCases":[],"_links":{"self":"/api/acts/financial-sector-collection-of-data-reporting-standard-determination-no-32-of-2015","history":"/api/acts/financial-sector-collection-of-data-reporting-standard-determination-no-32-of-2015/history","analysis":"/api/acts/financial-sector-collection-of-data-reporting-standard-determination-no-32-of-2015/analysis","conflicts":"/api/acts/financial-sector-collection-of-data-reporting-standard-determination-no-32-of-2015/conflicts","importantCases":"/api/acts/financial-sector-collection-of-data-reporting-standard-determination-no-32-of-2015/important-cases","documents":"/api/acts/financial-sector-collection-of-data-reporting-standard-determination-no-32-of-2015/documents"}}